These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16055332)

  • 21. Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration.
    Sirisoma N; Pervin A; Zhang H; Jiang S; Willardsen JA; Anderson MB; Mather G; Pleiman CM; Kasibhatla S; Tseng B; Drewe J; Cai SX
    J Med Chem; 2009 Apr; 52(8):2341-51. PubMed ID: 19296653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
    Park HJ; Kim YS; Kim JS; Lee EJ; Yi YJ; Hwang HJ; Suh ME; Ryu CK; Lee SK
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3385-8. PubMed ID: 15177438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src.
    Plé PA; Green TP; Hennequin LF; Curwen J; Fennell M; Allen J; Lambert-Van Der Brempt C; Costello G
    J Med Chem; 2004 Feb; 47(4):871-87. PubMed ID: 14761189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
    Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
    J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor.
    Smaill JB; Showalter HD; Zhou H; Bridges AJ; McNamara DJ; Fry DW; Nelson JM; Sherwood V; Vincent PW; Roberts BJ; Elliott WL; Denny WA
    J Med Chem; 2001 Feb; 44(3):429-40. PubMed ID: 11462982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2).
    Heidebrecht RW; Chenard M; Close J; Dahlberg WK; Fleming J; Grimm JB; Hamill JE; Harsch A; Haines BB; Hughes B; Kral AM; Middleton RE; Mushti C; Ozerova N; Szewczak AA; Wang H; Wilson K; Witter DJ; Secrist JP; Miller TA
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2053-8. PubMed ID: 19268585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
    Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and anti-proliferative activity of substituted-anilinoquinazolines and its relation to EGFR inhibition.
    El Ella DA; Saleh KA; Hassan M; Hamdy N; El-Araby ME; Abouzid KA
    Arzneimittelforschung; 2012 Aug; 62(8):360-6. PubMed ID: 22723174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors.
    Zificsak CA; Theroff JP; Aimone LD; Angeles TS; Albom MS; Cheng M; Mesaros EF; Ott GR; Quail MR; Underiner TL; Wan W; Dorsey BD
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3877-80. PubMed ID: 21632243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of bis(methoxy methyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines as EGFR tyrosine kinase inhibitors.
    Lee YS; Seo SH; Yang BS; Lee JY
    Arch Pharm (Weinheim); 2005 Oct; 338(10):502-5. PubMed ID: 16211656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors.
    Jung FH; Pasquet G; Lambert-van der Brempt C; Lohmann JJ; Warin N; Renaud F; Germain H; De Savi C; Roberts N; Johnson T; Dousson C; Hill GB; Mortlock AA; Heron N; Wilkinson RW; Wedge SR; Heaton SP; Odedra R; Keen NJ; Green S; Brown E; Thompson K; Brightwell S
    J Med Chem; 2006 Feb; 49(3):955-70. PubMed ID: 16451062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer.
    Chen Z; Venkatesan AM; Dehnhardt CM; Dos Santos O; Delos Santos E; Ayral-Kaloustian S; Chen L; Geng Y; Arndt KT; Lucas J; Chaudhary I; Mansour TS
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4980-3. PubMed ID: 19640711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arylcarboxyamino-substituted diaryl ureas as potent and selective FLT3 inhibitors.
    Patel HK; Grotzfeld RM; Lai AG; Mehta SA; Milanov ZV; Chao Q; Sprankle KG; Carter TA; Velasco AM; Fabian MA; James J; Treiber DK; Lockhart DJ; Zarrinkar PP; Bhagwat SS
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5182-5. PubMed ID: 19646870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase.
    Yano S; Kazuno H; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3431-41. PubMed ID: 15186829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis.
    Tripathy R; Reiboldt A; Messina PA; Iqbal M; Singh J; Bacon ER; Angeles TS; Yang SX; Albom MS; Robinson C; Chang H; Ruggeri BA; Mallamo JP
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2158-62. PubMed ID: 16460933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays.
    Noronha G; Barrett K; Boccia A; Brodhag T; Cao J; Chow CP; Dneprovskaia E; Doukas J; Fine R; Gong X; Gritzen C; Gu H; Hanna E; Hood JD; Hu S; Kang X; Key J; Klebansky B; Kousba A; Li G; Lohse D; Mak CC; McPherson A; Palanki MS; Pathak VP; Renick J; Shi F; Soll R; Splittgerber U; Stoughton S; Tang S; Yee S; Zeng B; Zhao N; Zhu H
    Bioorg Med Chem Lett; 2007 Feb; 17(3):602-8. PubMed ID: 17113292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
    Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
    Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533).
    Choi H; Lee J; Kim YH; Im DS; Hwang IC; Kim SJ; Moon SK; Lee HW; Lee SS; Ahn SK; Kim SW; Choi NS; Lee KJ
    Bioorg Med Chem Lett; 2010 Jan; 20(1):383-6. PubMed ID: 19906530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase.
    Cumming JG; McKenzie CL; Bowden SG; Campbell D; Masters DJ; Breed J; Jewsbury PJ
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5389-94. PubMed ID: 15454232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit.
    Hu E; Tasker A; White RD; Kunz RK; Human J; Chen N; Bürli R; Hungate R; Novak P; Itano A; Zhang X; Yu V; Nguyen Y; Tudor Y; Plant M; Flynn S; Xu Y; Meagher KL; Whittington DA; Ng GY
    J Med Chem; 2008 Jun; 51(11):3065-8. PubMed ID: 18447379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.